Skip to search formSkip to main contentSkip to account menu

Repronex

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

MenotropinsOrganic Chemicals

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Impact of gonadotropins on oocyte maturation, fertilisation and developmental competence in vitro.
The aim of the present study was to evaluate the dose-dependent effects of gonadotropins, either singly (Bravelle (B), Luveris (L… 
2004
2004
Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization.
Review
2003
Review
2003
Urofollitropin - Ferring: FERRING hFSH, hFSH - Ferring, human follicle-stimulating hormone - Ferring, Bravelle.
Ferring Pharmaceuticals (US) is developing a highly purified form of urofollitropin [human follicle-stimulating hormone, hFSH… 
2003
2003
Evaluation of mixed protocols with Bravelle (hFSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE): a comparison of patients 18–33 years and 34–40 years undergoing in vitro fertilization
2000
2000
Subcutaneously administered Repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment. Repronex SC, IVF Study Group.
OBJECTIVE To determine the efficacy and safety of Repronex SC as compared with Repronex IM and Pergonal IM in patients undergoing… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)